The Concept of CMR
Slides, videos and moreNews
- Categories
Editorials
News
Abdominal Obesity / Body Fat Distribution- Acute Coronary Syndromes
- Adipokines
- Adipose Tissue
- Age
- Cardiometabolic Risk
- Cardiovascular Disease
- Childhood Obesity
- Clinical Cardiology
- Clinical Trials
- Diabetes
- Ectopic Fat
- Epidemiology
- Ethnicity
- Gender Differences
- Genetics
- Hypertension
- Inflammation
- Insulin Resistance
- Interventional Cardiology
- Lipids/Lipoproteins
- Menopause
- Metabolic Syndrome
- Metabolism
- Metabolism: Animal Studies
- Metabolism: Human Studies
- Nutrition
- Obesity
- Physical Activity/Exercise
- Prevention
- Smoking
- Steroid Hormones
- Thrombosis
- Type 2 Diabetes
- Weight Loss
- December 31, 2009Lipids/Lipoproteins, News
- Nonpharmacologic treatment of dyslipidemia. Prog Cardiovasc Dis 2009;52:61-94
Houston MC, Fazio S, Chilton FH, Wise DE, Jones KB, Barringer TA, Bramlet DA.
This paper reviews the non-pharmacologic treatment strategies to treat dyslipidemia which is one of the major risk factors for cardiovascular disease. All...
- December 31, 2009Diabetes, Insulin Resistance, News
- Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009;361:1736-47
Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group.
In this study, 708 patients who had sub-optimal glycated hemoglobin levels while taking metformin and sulfonylurea were randomly assigned to receive...
- December 30, 2009Cardiovascular Disease, News, Nutrition
- Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease--eat fish or take fish oil supplement? Prog Cardiovasc Dis 2009;52:95-114
He K.
This review summarizes the epidemiology of fish or omega-3 fatty acids and their relationships with cardiovascular disease (CVD) as well as coronary heart disease mortality and stroke. Several studies are in favour of a cardioprotective...
- December 30, 2009Diabetes, Insulin Resistance, News
- Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 2009;32:1583-8
Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF; Diabetes Prevention Program Research Group.
The purpose of this study was to examine the effect of baseline characteristics on regression from pre-diabetes to normal glucose regulation...
- December 29, 2009News, Obesity
- CB1 antagonists for obesity--what lessons have we learned from rimonabant? Nat Rev Endocrinol 2009;5:633-8
Di Marzo V, Després JP.
In this commentary, the authors review the history of the discovery of the endocannabinoid system, the development of CB1 antagonists and the experience of Rimonabant and its suspension following psychiatric adverse...